Advertisement

Author: Andrew Cass

Blue Cross Blue Shield of Vermont has filed a federal lawsuit accusing Teva Pharmaceuticals of acting anticompetitively to force health insurers to pay billions of dollars for its "excessively priced" multiple sclerosis drug, Copaxone, Law Street Media reported Aug. 22. 

Blue Shield of California President and CEO Paul Markovich told America's Health Insurance Plans Aug. 22 that three critical issues must be addressed by healthcare delivery systems to make them more effective in meeting consumer needs. 

Advertisement
Advertisement